Hechtman H B, Reid M H, Dorn B C, Weisel R D
J Clin Invest. 1973 May;52(5):1215-29. doi: 10.1172/JCI107289.
A new triple tracer indicator dilution technique has been used to measure alveolar ventilation as well as air and tissue volumes in the lungs of experimental animals and man. The tracers indocyanine green, [(121)I]antipyrine and xenon-133 were rapidly injected into the right atrium, while sampling was carried out from a peripheral artery. Blood flow and tissue volumes were obtained by classical analysis of the indocyanine green and antipyrine concentration-time curves. A double exit-port, constant air flow model was used to analyze the xenon curves, because ventilatory loss led to incomplete recovery of the gas tracer in effluent blood. Uniform ventilation and perfusion were assumed. This analysis permitted calculation of alveolar ventilation (VA(Xe)) and functional residual capacity (FRC(Xe)) during normal breathing. In control studies, VA(Xe) was similar to VA(co2), obtained with the steady-state CO(2) method (r = 0.87), while in critically ill patients the xenon measurement was significantly lower, averaging 54% of VA(co2). In theory, underestimates in VA(Xe) and decrease in the ratio VA(Xe)/VA(co2) relate to nonuniformity in regional ventilation and perfusion. The effect is greatest for the slightly soluble gas, xenon. The significant inverse correlation between VA(Xe)/VA(co2) and the physiologic shunt is consistent with this postulate.FRC(Xe) was similar to the predicted FRC in animals but was 76% of the helium measured FRC in patients. FRC(Xe) was significantly lower than the xenon measured air volumes during breath-holding when nonuniformity of ventilation was not operative. Lung tissue volumes in animals were 83% of gravimetric lung weights, while in patients the volumes were much lower than predicted. Nonhomogeneous lung function, including failure to perfuse the entire capillary bed, with resultant incomplete penetration of tracers into all segments of lung air and tissue, may explain these findings. The resultant errors can be significant in sick patients, and may themselves be used to study nonhomogeneities in the distribution of ventilation and volume.
一种新的三重示踪剂指示剂稀释技术已被用于测量实验动物和人类肺部的肺泡通气以及空气和组织容积。将吲哚菁绿、[¹²¹I]安替比林和氙-133快速注入右心房,同时从外周动脉进行采样。通过对吲哚菁绿和安替比林浓度-时间曲线的经典分析获得血流量和组织容积。使用双出口端口、恒定气流模型来分析氙曲线,因为通气损失导致气体示踪剂在流出血液中不能完全回收。假设通气和灌注均匀。该分析允许计算正常呼吸时的肺泡通气量(VA(Xe))和功能残气量(FRC(Xe))。在对照研究中,VA(Xe)与用稳态CO₂法获得的VA(co₂)相似(r = 0.87),而在危重病患者中,氙测量值明显较低,平均为VA(co₂)的54%。理论上,VA(Xe)的低估和VA(Xe)/VA(co₂)比值的降低与区域通气和灌注的不均匀性有关。对于微溶性气体氙,这种影响最大。VA(Xe)/VA(co₂)与生理分流之间的显著负相关与这一假设一致。FRC(Xe)在动物中与预测的FRC相似,但在患者中是用氦气测量的FRC的76%。当通气不均匀不起作用时,FRC(Xe)明显低于屏气时测量的氙气空气容积。动物的肺组织容积为重量法肺重量的83%,而在患者中,容积远低于预测值。包括未能灌注整个毛细血管床在内的不均匀肺功能,导致示踪剂不能完全渗透到肺空气和组织的所有节段,可能解释了这些发现。由此产生的误差在患病患者中可能很大,并且它们本身可用于研究通气和容积分布的不均匀性。